Annual Current Liabilities
$20.08 M
-$27.76 M-58.03%
December 31, 2023
Summary
- As of February 10, 2025, NGM annual total current liabilities is $20.08 million, with the most recent change of -$27.76 million (-58.03%) on December 31, 2023.
- During the last 3 years, NGM annual current liabilities has fallen by -$22.50 million (-52.84%).
Performance
NGM Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Liabilities
$20.08 M
-$2.26 M-10.13%
December 31, 2023
Summary
- As of February 10, 2025, NGM quarterly total current liabilities is $20.08 million, with the most recent change of -$2.26 million (-10.13%) on December 31, 2023.
- Over the past year, NGM quarterly current liabilities has dropped by -$17.82 million (-47.02%).
Performance
NGM Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
NGM Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -58.0% | -47.0% |
| 3 y3 years | -52.8% | -52.8% |
| 5 y5 years | -51.6% | -51.6% |
NGM Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -67.3% | at low | -67.3% | at low |
| 5 y | 5-year | -67.3% | at low | -67.3% | at low |
| alltime | all time | -67.3% | at low | -67.3% | at low |
NGM Biopharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $20.08 M(-58.0%) | $20.08 M(-10.1%) |
| Sep 2023 | - | $22.34 M(-21.4%) |
| Jun 2023 | - | $28.42 M(-25.0%) |
| Mar 2023 | - | $37.90 M(-20.8%) |
| Dec 2022 | $47.84 M(-22.0%) | $47.84 M(-1.6%) |
| Sep 2022 | - | $48.60 M(+14.2%) |
| Jun 2022 | - | $42.54 M(-4.5%) |
| Mar 2022 | - | $44.56 M(-27.4%) |
| Dec 2021 | $61.35 M(+44.1%) | $61.35 M(+6.3%) |
| Sep 2021 | - | $57.73 M(+28.2%) |
| Jun 2021 | - | $45.04 M(+11.7%) |
| Mar 2021 | - | $40.31 M(-5.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $42.58 M(+7.2%) | $42.58 M(+12.9%) |
| Sep 2020 | - | $37.72 M(+11.9%) |
| Jun 2020 | - | $33.70 M(+18.4%) |
| Mar 2020 | - | $28.46 M(-28.3%) |
| Dec 2019 | $39.72 M(-4.3%) | $39.72 M(-1.9%) |
| Sep 2019 | - | $40.48 M(+4.7%) |
| Jun 2019 | - | $38.65 M(-9.9%) |
| Mar 2019 | - | $42.88 M(+3.4%) |
| Dec 2018 | $41.49 M(+12.4%) | $41.49 M(+6.6%) |
| Jun 2018 | - | $38.90 M(+5.4%) |
| Dec 2017 | $36.89 M(-2.1%) | $36.89 M |
| Dec 2016 | $37.69 M | - |
FAQ
- What is NGM Biopharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals annual current liabilities year-on-year change?
- What is NGM Biopharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals quarterly current liabilities year-on-year change?
What is NGM Biopharmaceuticals annual total current liabilities?
The current annual current liabilities of NGM is $20.08 M
What is the all time high annual current liabilities for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high annual total current liabilities is $61.35 M
What is NGM Biopharmaceuticals annual current liabilities year-on-year change?
Over the past year, NGM annual total current liabilities has changed by -$27.76 M (-58.03%)
What is NGM Biopharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of NGM is $20.08 M
What is the all time high quarterly current liabilities for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high quarterly total current liabilities is $61.35 M
What is NGM Biopharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, NGM quarterly total current liabilities has changed by -$17.82 M (-47.02%)